文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

氯胺酮与氯胺酮-丙泊酚合剂用于成人程序性镇静的不良事件:双盲随机对照试验

Adverse Events With Ketamine Versus Ketofol for Procedural Sedation on Adults: A Double-blind, Randomized Controlled Trial.
PubMed 文献 · Acad Emerg Med · 2017-07-14
一句话结论成人急诊程序性镇静中,氯胺酮-丙泊酚1:1合剂较氯胺酮单药使恢复期不良反应发生率降低22%、呕吐减少三倍。

本多中心随机双盲试验纳入152例接受急诊程序性镇静的成人患者,氯胺酮组与氯胺酮-丙泊酚1:1合剂(氯胺酮-丙泊酚合剂)组各76例。主要终点恢复期不愉快反应发生率方面,氯胺酮-丙泊酚合剂较氯胺酮降低22%(P<0.01),且因这些反应所需的临床和药物干预更少。两组均无严重不良事件,血流动力学事件、呼吸事件及满意度评分相似;氯胺酮-丙泊酚合剂组呕吐发生率较氯胺酮组降低三倍。作者结论为氯胺酮-丙泊酚合剂可显著减少成人急诊程序性镇静的恢复期反应和呕吐频率。

要点

  • 成人急诊程序性镇静中,氯胺酮-丙泊酚合剂组恢复期不愉快反应发生率较氯胺酮组降低22%(P<0.01)。
  • 氯胺酮-丙泊酚合剂组因恢复期反应所需的临床和药物干预均少于氯胺酮组。
  • 氯胺酮-丙泊酚合剂组呕吐发生率较氯胺酮组降低三倍。
  • 两组均无严重不良事件,血流动力学事件、呼吸事件发生率及患者与操作者满意度评分相似。

适用人群与场景

  • 接受急诊程序性镇静的成人患者,共152例完成研究,氯胺酮组76例、氯胺酮-丙泊酚合剂组76例。

处置流程与药物剂量

  • 氯胺酮-丙泊酚合剂为氯胺酮与丙泊酚1:1混合液,用于成人急诊程序性镇静。
  • 对照干预为氯胺酮单药用于成人急诊程序性镇静。

研究设计与关键结果

  • 多中心随机双盲试验,152例成人急诊程序性镇静患者,氯胺酮-丙泊酚合剂组与氯胺酮组各76例。
  • 主要终点恢复期不愉快反应发生率:氯胺酮-丙泊酚合剂较氯胺酮降低22%(P<0.01)。
  • 氯胺酮-丙泊酚合剂组因恢复期反应所需的临床和药物干预少于氯胺酮组。
  • 两组均无严重不良事件;血流动力学事件、呼吸事件发生率及满意度评分相似。
  • 氯胺酮-丙泊酚合剂组呕吐发生率较氯胺酮组降低三倍。

证据类型、等级与局限

  • 证据类型:多中心随机双盲对照试验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,成人急诊程序性镇静选用氯胺酮-丙泊酚合剂较氯胺酮可减少恢复期不愉快反应及呕吐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: The goal of our study was to compare the frequency and severity of recovery reactions between ketamine and ketamine-propofol 1:1 admixture ("ketofol").

METHODS: We performed a multicentric, randomized, double-blind trial in which adult patients received emergency procedural sedations with ketamine or ketofol. Our primary outcome was the proportion of unpleasant recovery reactions. Other outcomes were frequency of interventions required by these recovery reactions, rates of respiratory or hemodynamic events, emesis, and satisfaction of patients as well as providers.

RESULTS: A total of 152 patients completed the study, 76 in each arm. Compared with ketamine, ketofol determined a 22% reduction in recovery reactions incidence (p < 0.01) and less clinical and pharmacologic interventions required by these reactions. There was no serious adverse event in both groups. Rates in hemodynamic or respiratory events as well as satisfaction scores were similar. Significantly fewer patients experienced emesis with ketofol, with a threefold reduction in incidence compared with ketamine.

CONCLUSION: We found a significant reduction in recovery reactions and emesis frequencies among adult patients receiving emergency procedural sedations with ketofol, compared with ketamine.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Lemoel F, Contenti J, Giolito D, et al. Adverse Events With Ketamine Versus Ketofol for Procedural Sedation on Adults: A Double-blind, Randomized Controlled Trial. Acad Emerg Med. 2017. PMID: 28493642. doi:10.1111/acem.13226

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。